Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Huff

Showing results (251-260 of 312) with videos related to

Pageof 32
Sort By:
Journal of Pediatric Surgery|June 1, 1987
Fetal hydronephrosis: selection and surgical repairM R Harrison, M S Golbus, R A Filly, et al.
Atherosclerosis|May 19, 2019
Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr<sup>-/-</sup> miceAmy C Burke, Brian G Sutherland, Dawn E Telford, et al.
Circulation Research|September 27, 2003
Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formationAndrea H Rowe, Carmen A Argmann, Jane Y Edwards, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat liversI I Singer, D W Kawka, D M Kazazis, et al.
Journal of Medicinal Chemistry|February 1, 1990
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-onesJ D Prugh, A W Alberts, A A Deana, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 10, 2008
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemiaJian Wang, Matthew R Ban, Brooke A Kennedy, et al.
Endocrinology|October 28, 1999
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Journal of Lipid Research|July 7, 1999
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Mutation Research|November 14, 1997
Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart diseaseA K Kang, D J Jenkins, T M Wolever, et al.
Pageof 32

Showing results (251-260 of 312) with videos related to

Sort By:
Pageof 32
Journal of Pediatric Surgery|June 1, 1987
Fetal hydronephrosis: selection and surgical repairM R Harrison, M S Golbus, R A Filly, et al.
Atherosclerosis|May 19, 2019
Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr<sup>-/-</sup> miceAmy C Burke, Brian G Sutherland, Dawn E Telford, et al.
Circulation Research|September 27, 2003
Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formationAndrea H Rowe, Carmen A Argmann, Jane Y Edwards, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat liversI I Singer, D W Kawka, D M Kazazis, et al.
Journal of Medicinal Chemistry|February 1, 1990
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-onesJ D Prugh, A W Alberts, A A Deana, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 10, 2008
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemiaJian Wang, Matthew R Ban, Brooke A Kennedy, et al.
Endocrinology|October 28, 1999
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Journal of Lipid Research|July 7, 1999
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigsJ R Burnett, L J Wilcox, D E Telford, et al.
Mutation Research|November 14, 1997
Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart diseaseA K Kang, D J Jenkins, T M Wolever, et al.
Pageof 32